SCHEMBL5899446

SCHEMBL5899446

COc1ccc(S(=O)(=O)NCC(=O)c2ccc3ccccc3c2)cc1OC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 4/20 0.72
POLB P06746 1/20 0.54
NPSR1 Q6W5P4 1/20 0.53
HCRTR1 O43613 1/20 0.51
ALDH1A1 P00352 2/20 0.50
MAPK1 P28482 1/20 0.50
CTSS P25774 1/20 0.49
TSHR P16473 1/20 0.49
HSD17B10 Q99714 1/20 0.49
NPC1 O15118 1/20 0.49
NQO2 P16083 1/20 0.49
CASP3 P42574 1/20 0.49
RAB9A P51151 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899490 0.87 KAT6A (0.62) KAT6ANPSR1ALDH1A1MAPK1TSHR
SCHEMBL5899462 0.81 KAT6A (0.71) KAT6APOLBALDH1A1CTSSKMT2A
SCHEMBL5899507 0.80 KAT6A (0.66) KAT6APOLBALDH1A1
SCHEMBL5899421 0.79 KAT6A (0.65) KAT6APOLBALDH1A1CTSSNPC1
SCHEMBL5899491 0.79 KAT6A (0.62) KAT6APOLBALDH1A1CTSSNPC1
SCHEMBL5899477 0.79 KAT6A (0.65) KAT6APOLBALDH1A1CTSSHDAC1
SCHEMBL10455943 0.77 CTNNB1 (0.66) POLBALDH1A1TSHRHSD17B10NPC1
SCHEMBL5171144 0.77 KMT2A (0.59) POLBNPSR1ALDH1A1MAPK1TSHR
SCHEMBL9895995 0.74 HTT (0.75) POLBNPSR1ALDH1A1
SCHEMBL23832459 0.74 RAPGEF3 (0.81) POLBNPSR1RAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 KAT6A 2440/4885POLB 1440/4885NPSR1 2055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.